Systematic review / meta-analysis / 2019
A meta-analysis found curcumin improved cognitive scores in older adults, while treated Alzheimer's patients showed a trend to do worse than placebo on the MMSE.
A systematic review and meta-analysis of six randomized controlled trials totaling 289 subjects evaluated curcumin for cognitive function. For older adults, curcumin improved cognitive function scores (SMD = 0.33, 95% CI [0.05, 0.62]; p = 0.02), with adverse events OR = 5.59 (95% CI [0.96, 36.80]; p = 0.05) and depression measures SMD = -0.29 (95% CI [0.64, 0.05]; p = 0.09). In Alzheimer's disease patients, cognition scores indicated a trend for treated subjects to do worse than placebo on the Mini-Mental State Examination (SMD = -0.90, 95% CI [1.48, -0.32]; p = 0.002). Limitations noted were a small number of studies, preventing funnel plot or sensitivity analysis, and insufficient data for schizophrenia outcomes.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 289 subjects across 6 randomized controlled trials (including older adults and Alzheimer's disease patients)
- What was measured
- Cognitive function, adverse events, depression measures
THE PAPER
Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis.
Zhu LN, Mei X, Zhang ZG, Xie YP, Lang F. Phytother Res, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.